Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2015

May 5, 2015

30071_dirs_2015-05-05_a7104080-dc2e-4704-a828-c3ae5303a4d4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-05-01

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-05-01 ResMed Common Stock S 500 $63.92 Disposed 57338.764 Indirect
2015-05-01 ResMed Common Stock M 5833 $19.25 Acquired 63171.764 Indirect
2015-05-01 ResMed Common Stock S 5833 $63.92 Disposed 57338.764 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-05-01 ResMed Common Stock Options $19.25 M 5833 Disposed 2016-02-03 ResMed Common Stock (5833) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 42662 Direct

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest 1/4 per year on the anniversary of the grant.

F3: Includes 218.410 shares of common stock purchased on April 30, 2015, through ResMed's Employee Stock Purchase Plan.